Iterum Therapeutics Ownership 2024 | Who Owns Iterum Therapeutics Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

0.00%

Insider Ownership

1.81%

Retail Ownership

98.19%

Institutional Holders

1.00

Iterum Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0.00%	-	66	-	-	76	Jun 30, 2024
ANCORA ADVISORS, LLC	-	-	-	-38	-100.00%	-	Jun 30, 2024

Iterum Therapeutics's largest institutional shareholder is BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC, holding 0.00% of the company's total share outstanding, currently valued at $76.00. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0.00%	-	66	-	-	76	Jun 30, 2024
ANCORA ADVISORS, LLC	-	-	-	-38	-100.00%	-	Jun 30, 2024

The largest Iterum Therapeutics shareholder by % of total assets is BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC. The company owns 66.00 shares of Iterum Therapeutics (ITRM), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0.00%	-	66	-	-	76	Jun 30, 2024
ANCORA ADVISORS, LLC	-	-	-	-38	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Iterum Therapeutics's largest institutional buyer is BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC. The company purchased 0.00 stocks of ITRM, valued at $76.00.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANCORA ADVISORS, LLC	-	-	-	-38	-100.00%	-	Jun 30, 2024
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	0.00%	-	66	-	-	76	Jun 30, 2024

As of Jun 30 2024, Iterum Therapeutics's biggest institutional seller is ANCORA ADVISORS, LLC. The company sold -38.00 shares of ITRM, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANCORA ADVISORS, LLC	-	-	-	-38	-100.00%	-	Jun 30, 2024

Iterum Therapeutics's largest sold out institutional shareholder by shares sold is ANCORA ADVISORS, LLC, sold -38.00 shares, valued at -, as of undefined.

Iterum Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
Destra Investment Trust	0.00%	783	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	35,935	-	-	Jan 31, 2024

Iterum Therapeutics's largest mutual fund holder by % of total assets is "Destra Investment Trust", owning 783.00 shares, compromising 0.00% of its total assets.

Iterum Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	1	-50.00%
31 Mar, 24	2	-
31 Dec, 23	2	-
30 Sep, 23	2	-
30 Jun, 23	2	-
31 Mar, 23	2	-33.33%
31 Dec, 22	3	-25.00%
30 Sep, 22	4	-86.21%
30 Jun, 22	29	-
31 Mar, 22	29	-14.71%
31 Dec, 21	34	-
30 Sep, 21	34	-12.82%
30 Jun, 21	39	-13.33%
31 Mar, 21	45	136.84%
31 Dec, 20	19	58.33%
30 Sep, 20	12	20.00%
30 Jun, 20	10	-28.57%
31 Mar, 20	14	7.69%
31 Dec, 19	13	-27.78%
30 Sep, 19	18	-5.26%
30 Jun, 19	19	-
31 Mar, 19	19	-13.64%
31 Dec, 18	22	10.00%
30 Sep, 18	20	-16.67%
30 Jun, 18	24	-

As of 30 Jun 24, 1 institutions are holding Iterum Therapeutics's shares, representing a decrease of -50.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	66	-36.54%
31 Mar, 24	104	-
31 Dec, 23	104	-
30 Sep, 23	104	-
30 Jun, 23	104	-
31 Mar, 23	104	-69.77%
31 Dec, 22	344	-99.69%
30 Sep, 22	110,950	-98.11%
30 Jun, 22	5,880,694	15.52%
31 Mar, 22	5,090,678	-22.33%
31 Dec, 21	6,554,310	7.65%
30 Sep, 21	6,088,689	-46.92%
30 Jun, 21	11,471,379	44.15%
31 Mar, 21	7,958,118	13.95%
31 Dec, 20	6,983,824	40.38%
30 Sep, 20	4,974,883	-19.23%
30 Jun, 20	6,159,402	-12.46%
31 Mar, 20	7,036,339	-0.43%
31 Dec, 19	7,066,437	18.23%
30 Sep, 19	5,976,908	-1.79%
30 Jun, 19	6,085,777	-0.93%
31 Mar, 19	6,143,119	-2.48%
31 Dec, 18	6,299,203	-0.74%
30 Sep, 18	6,346,311	-4.49%
30 Jun, 18	6,644,337	-

Iterum Therapeutics (ITRM) has 66.00 shares outstanding as of 30 Jun 24, down -36.54% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.00%	67750.00%
31 Mar, 24	0.00%	123662.50%
31 Dec, 23	0.00%	124075.00%
30 Sep, 23	0.00%	122475.00%
30 Jun, 23	0.00%	125000.00%
31 Mar, 23	0.00%	10417.86%
31 Dec, 22	0.00%	0.34%
30 Sep, 22	0.91%	8.82%
30 Jun, 22	3.21%	41.40%
31 Mar, 22	2.78%	17.29%
31 Dec, 21	4.01%	36.14%
30 Sep, 21	3.33%	8.21%
30 Jun, 21	6.37%	14.87%
31 Mar, 21	6.55%	19.83%
31 Dec, 20	5.75%	34.30%
30 Sep, 20	4.09%	15.94%
30 Jun, 20	5.07%	15.12%
31 Mar, 20	5.79%	17.13%
31 Dec, 19	5.81%	24.04%
30 Sep, 19	4.92%	19.62%
30 Jun, 19	5.01%	19.60%
31 Mar, 19	5.05%	18.82%
31 Dec, 18	5.18%	19.01%
30 Sep, 18	5.22%	17.47%
30 Jun, 18	5.47%	-

As of 30 Jun 24, Iterum Therapeutics is held by 0.00% institutional shareholders, representing a 67750.00% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	1	-
31 Dec, 23	-	-
30 Sep, 23	-	-
30 Jun, 23	-	-100.00%
31 Mar, 23	1	-50.00%
31 Dec, 22	2	-
30 Sep, 22	-	-100.00%
30 Jun, 22	11	37.50%
31 Mar, 22	8	-27.27%
31 Dec, 21	11	-21.43%
30 Sep, 21	14	-26.32%
30 Jun, 21	19	-47.22%
31 Mar, 21	36	176.92%
31 Dec, 20	13	116.67%
30 Sep, 20	6	50.00%
30 Jun, 20	4	-33.33%
31 Mar, 20	6	20.00%
31 Dec, 19	5	66.67%
30 Sep, 19	3	50.00%
30 Jun, 19	2	100.00%
31 Mar, 19	1	-75.00%
31 Dec, 18	4	-20.00%
30 Sep, 18	5	-79.17%
30 Jun, 18	24	-

- institutional shareholders have increased their position in ITRM stock as of 30 Jun 24 compared to 1 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-
31 Mar, 24	-	-
31 Dec, 23	-	-
30 Sep, 23	-	-
30 Jun, 23	-	-
31 Mar, 23	-	-100.00%
31 Dec, 22	1	-66.67%
30 Sep, 22	3	-25.00%
30 Jun, 22	4	-
31 Mar, 22	4	-42.86%
31 Dec, 21	7	16.67%
30 Sep, 21	6	-25.00%
30 Jun, 21	8	700.00%
31 Mar, 21	1	-
31 Dec, 20	-	-100.00%
30 Sep, 20	1	-
30 Jun, 20	1	-50.00%
31 Mar, 20	2	100.00%
31 Dec, 19	1	-87.50%
30 Sep, 19	8	-27.27%
30 Jun, 19	11	-8.33%
31 Mar, 19	12	71.43%
31 Dec, 18	7	-12.50%
30 Sep, 18	8	-
30 Jun, 18	-	-

- institutional shareholders have reduced their position in ITRM stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	1	-50.00%	66	-36.54%	0.00%	67750.00%	-	-100.00%	-	-
31 Mar, 24	2	-	104	-	0.00%	123662.50%	1	-	-	-
31 Dec, 23	2	-	104	-	0.00%	124075.00%	-	-	-	-
30 Sep, 23	2	-	104	-	0.00%	122475.00%	-	-	-	-
30 Jun, 23	2	-	104	-	0.00%	125000.00%	-	-100.00%	-	-
31 Mar, 23	2	-33.33%	104	-69.77%	0.00%	10417.86%	1	-50.00%	-	-100.00%
31 Dec, 22	3	-25.00%	344	-99.69%	0.00%	0.34%	2	-	1	-66.67%
30 Sep, 22	4	-86.21%	110,950	-98.11%	0.91%	8.82%	-	-100.00%	3	-25.00%
30 Jun, 22	29	-	5,880,694	15.52%	3.21%	41.40%	11	37.50%	4	-
31 Mar, 22	29	-14.71%	5,090,678	-22.33%	2.78%	17.29%	8	-27.27%	4	-42.86%
31 Dec, 21	34	-	6,554,310	7.65%	4.01%	36.14%	11	-21.43%	7	16.67%
30 Sep, 21	34	-12.82%	6,088,689	-46.92%	3.33%	8.21%	14	-26.32%	6	-25.00%
30 Jun, 21	39	-13.33%	11,471,379	44.15%	6.37%	14.87%	19	-47.22%	8	700.00%
31 Mar, 21	45	136.84%	7,958,118	13.95%	6.55%	19.83%	36	176.92%	1	-
31 Dec, 20	19	58.33%	6,983,824	40.38%	5.75%	34.30%	13	116.67%	-	-100.00%
30 Sep, 20	12	20.00%	4,974,883	-19.23%	4.09%	15.94%	6	50.00%	1	-
30 Jun, 20	10	-28.57%	6,159,402	-12.46%	5.07%	15.12%	4	-33.33%	1	-50.00%
31 Mar, 20	14	7.69%	7,036,339	-0.43%	5.79%	17.13%	6	20.00%	2	100.00%
31 Dec, 19	13	-27.78%	7,066,437	18.23%	5.81%	24.04%	5	66.67%	1	-87.50%
30 Sep, 19	18	-5.26%	5,976,908	-1.79%	4.92%	19.62%	3	50.00%	8	-27.27%
30 Jun, 19	19	-	6,085,777	-0.93%	5.01%	19.60%	2	100.00%	11	-8.33%
31 Mar, 19	19	-13.64%	6,143,119	-2.48%	5.05%	18.82%	1	-75.00%	12	71.43%
31 Dec, 18	22	10.00%	6,299,203	-0.74%	5.18%	19.01%	4	-20.00%	7	-12.50%
30 Sep, 18	20	-16.67%	6,346,311	-4.49%	5.22%	17.47%	5	-79.17%	8	-
30 Jun, 18	24	-	6,644,337	-	5.47%	-	24	-	-	-

Iterum Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 27, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	25,000	$1.40	$35.00K	113,754
Dec 19, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	10,000	$1.84	$18.44K	88,754
Nov 27, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	20,000	$2.03	$40.69K	78,754
Nov 20, 2023	Fishman Corey N.	director, officer	Chief Executive Officer	P-Purchase	Buy	10,000	$1.59	$15.86K	54,449

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 27, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	25,000	$1.40	$35.00K	113,754
Dec 19, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	10,000	$1.84	$18.44K	88,754
Nov 27, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	20,000	$2.03	$40.69K	78,754
Nov 20, 2023	Fishman Corey N.	director, officer	Chief Executive Officer	P-Purchase	Buy	10,000	$1.59	$15.86K	54,449

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 12, 2024	Dunne Michael W.	director	-	M-Exempt	Sell	212,494	$0.61	$129.62K	-
Aug 12, 2024	Fishman Corey N.	director, officer	Chief Executive Officer	M-Exempt	Sell	165,226	$0.61	$100.79K	-
Aug 12, 2024	HUNT RONALD	director	-	M-Exempt	Sell	130,962	$0.61	$79.89K	-
Dec 04, 2023	Puttagunta Sailaja	officer	Chief Medical Officer	M-Exempt	Sell	8,333	-	-	16,666
Dec 04, 2023	Puttagunta Sailaja	officer	Chief Medical Officer	F-InKind	Sell	2,933	$2.12	$6.22K	10,369
Oct 02, 2023	HUNT RONALD	director	-	M-Exempt	Sell	5,479	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 12, 2024	Dunne Michael W.	director	-	M-Exempt	Buy	106,247	$1.21	$128.56K	220,001
Aug 12, 2024	Dunne Michael W.	director	-	M-Exempt	Buy	106,247	$1.21	$128.56K	106,247
Aug 12, 2024	Dunne Michael W.	director	-	M-Exempt	Sell	212,494	$0.61	$129.62K	-
Aug 12, 2024	Fishman Corey N.	director, officer	Chief Executive Officer	M-Exempt	Buy	82,613	$1.21	$99.96K	137,062
Aug 12, 2024	Fishman Corey N.	director, officer	Chief Executive Officer	M-Exempt	Buy	82,613	$1.21	$99.96K	82,613
Aug 12, 2024	Fishman Corey N.	director, officer	Chief Executive Officer	M-Exempt	Sell	165,226	$0.61	$100.79K	-
Aug 12, 2024	HUNT RONALD	director	-	M-Exempt	Buy	182,453	$1.21	$220.77K	253,898
Aug 12, 2024	HUNT RONALD	director	-	M-Exempt	Buy	182,453	$1.21	$220.77K	182,453
Aug 12, 2024	HUNT RONALD	director	-	M-Exempt	Buy	65,481	$1.21	$79.23K	91,122
Aug 12, 2024	HUNT RONALD	director	-	M-Exempt	Buy	65,481	$1.21	$79.23K	65,481
Aug 12, 2024	HUNT RONALD	director	-	M-Exempt	Sell	130,962	$0.61	$79.89K	-
Dec 27, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	25,000	$1.40	$35.00K	113,754
Dec 19, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	10,000	$1.84	$18.44K	88,754
Dec 04, 2023	Puttagunta Sailaja	officer	Chief Medical Officer	M-Exempt	Sell	8,333	-	-	16,666
Dec 04, 2023	Puttagunta Sailaja	officer	Chief Medical Officer	A-Award	Buy	8,333	-	-	13,302
Dec 04, 2023	Puttagunta Sailaja	officer	Chief Medical Officer	F-InKind	Sell	2,933	$2.12	$6.22K	10,369
Nov 27, 2023	Dunne Michael W.	director	-	P-Purchase	Buy	20,000	$2.03	$40.69K	78,754
Nov 20, 2023	Fishman Corey N.	director, officer	Chief Executive Officer	P-Purchase	Buy	10,000	$1.59	$15.86K	54,449
Oct 02, 2023	HUNT RONALD	director	-	M-Exempt	Buy	5,479	-	-	14,346
Oct 02, 2023	HUNT RONALD	director	-	M-Exempt	Sell	5,479	-	-	-

The last insider sell of Iterum Therapeutics's stock was made by Dunne Michael W. on Aug 12 2024, selling 212,494 shares at $0.61 per share (valued at $129.62K). The last insider buy of ITRM was made by Dunne Michael W. on Dec 27 2023, buying 25,000 shares at $1.40 per share (worth $35.00K).

Iterum Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	6	4	150.00%
Q3 2023	2	2	100.00%
Q2 2023	6	5	120.00%
Q1 2023	7	6	116.67%
Q4 2022	4	2	200.00%
Q3 2022	-	-	-
Q2 2022	9	4	225.00%
Q1 2022	5	5	100.00%
Q4 2021	2	-	-
Q3 2021	1	-	-
Q2 2021	8	-	-
Q1 2021	9	7	128.57%
Q4 2020	2	-	-
Q3 2020	3	5	60.00%
Q2 2020	2	5	40.00%
Q1 2020	10	-	-
Q2 2019	13	7	185.71%
Q1 2019	3	-	-
Q4 2018	2	-	-
Q3 2018	5	-	-

6 total buy trades, and 4 total sell trades (buy/sell ratio of 1.50%) were made by Iterum Therapeutics's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	3	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	1	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	2	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	5	-
Q4 2020	2	-	-
Q3 2020	-	1	-
Q2 2020	-	2	-
Q1 2020	-	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	2	-	-
Q3 2018	5	-	-

As of Q4 2023, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Iterum Therapeutics's stocks.

Iterum Therapeutics Peer Ownership

Ticker	Company
HOTH	Hoth Therapeutics, Inc.
CFRX	ContraFect Corporation
ADIL	Adial Pharmaceuticals, Inc.
AEZS	Aeterna Zentaris Inc.
OCUP	Ocuphire Pharma, Inc.
REVB	Revelation Biosciences, Inc.
FBIO	Fortress Biotech, Inc.
CTXR	Citius Pharmaceuticals, Inc.
TNXP	Tonix Pharmaceuticals Holding Corp.
DFFN	CervoMed Inc.
FWBI	Entero Therapeutics, Inc.
JAGX	Jaguar Health, Inc.
DRMA	Dermata Therapeutics, Inc.
EYEN	Eyenovia, Inc.
VINC	Vincerx Pharma, Inc.
ONTX	Traws Pharma, Inc.
ACST	Acasti Pharma Inc.
VRCA	Verrica Pharmaceuticals Inc.
GRTX	Galera Therapeutics, Inc.

ITRM Ownership FAQ

Who Owns Iterum Therapeutics?

Iterum Therapeutics is owned by institutional shareholders (0.00%), insiders (1.81%), and public (98.19%). The largest institutional shareholder of Iterum Therapeutics is BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC (0.00% of total shares) and the top mutual fund owner is Destra Investment Trust (0.00% of total shares).

Who are the major institutional shareholders of Iterum Therapeutics?

Iterum Therapeutics's major institutional shareholders are BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC, and ANCORA ADVISORS, LLC. The top five shareholders own together 0.00% of the company's share outstanding.

How many Iterum Therapeutics shareholders are there?

As of Jun 2024, there are 1 institutional shareholders of Iterum Therapeutics.

What percentage of Iterum Therapeutics is owned by BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC?

BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC owns 66 shares of Iterum Therapeutics, representing 0.00% of the company's total shares outstanding, valued at $76 (as of Jun 2024).

What percentage of Iterum Therapeutics is owned by ANCORA ADVISORS, LLC?

As of Jun 2024, ANCORA ADVISORS, LLC holds 0 shares of Iterum Therapeutics (ITRM), compromising 0% of the company, valued at $0.